Trial intelligence / Profile preview

MVP Trial: Mechanism Guided vs PPI Strategy for LPR

NCT06999577Phase 4Recruiting

Sponsor
University of California, San Diego
Start
Jun 2025
Primary completion
May 2029
Modality
Small Molecules
Countries
1
01

Overview

A Phase 4 trial of omeprazole in laryngopharyngeal reflux (LPR), sponsored by University of California, San Diego. Started Jun 2025; status: recruiting.

02

Drugs

omeprazole
03

Conditions

laryngopharyngeal reflux (LPR)

Beyond the preview

Go deeper on NCT06999577.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT06999577.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call